This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1981 Oct;21(1):119-27.

doi: 10.1016/0090-1229(81)90200-2.

Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor

H Ratech, G J Thorbecke, R Hirschhorn

PMID: 6268339
DOI: 10.1016/0090-1229(81)90200-2

Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor

H Ratech et al. Clin Immunol Immunopathol. 1981 Oct.

. 1981 Oct;21(1):119-27.

doi: 10.1016/0090-1229(81)90200-2.

Authors

H Ratech, G J Thorbecke, R Hirschhorn

PMID: 6268339
DOI: 10.1016/0090-1229(81)90200-2

No abstract available

PubMed Disclaimer

Similar articles

Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
Ratech H, Hirschhorn R, Thorbecke GJ. Ratech H, et al. Am J Pathol. 1985 Apr;119(1):65-72. Am J Pathol. 1985. PMID: 3872599 Free PMC article.
Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
Smith CM, Henderson JF. Smith CM, et al. Biochem Pharmacol. 1982 Apr 15;31(8):1545-51. doi: 10.1016/0006-2952(82)90379-3. Biochem Pharmacol. 1982. PMID: 6980005
Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA, Thuillier L, Hamet M, Garreau F, Moncion A, Pérignon JL. Buc HA, et al. Clin Chim Acta. 1986 Apr 15;156(1):61-9. doi: 10.1016/0009-8981(86)90179-8. Clin Chim Acta. 1986. PMID: 3486057
Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
Hirschhorn R, Ratech H. Hirschhorn R, et al. Curr Top Hematol. 1983;4:1-35. Curr Top Hematol. 1983. PMID: 6413135 Review. No abstract available.
Inhibitors of adenosine deaminase.
Agarwal RP. Agarwal RP. Pharmacol Ther. 1982;17(3):399-429. doi: 10.1016/0163-7258(82)90023-7. Pharmacol Ther. 1982. PMID: 6187032 Review. No abstract available.

See all similar articles

Cited by

Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
Ratech H, Hirschhorn R, Thorbecke GJ. Ratech H, et al. Am J Pathol. 1985 Apr;119(1):65-72. Am J Pathol. 1985. PMID: 3872599 Free PMC article.
Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.
Brogden RN, Sorkin EM. Brogden RN, et al. Drugs. 1993 Oct;46(4):652-77. doi: 10.2165/00003495-199346040-00006. Drugs. 1993. PMID: 7506651 Review.
Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.
Ratech H, Hirschhorn R, Greco MA. Ratech H, et al. Am J Pathol. 1989 Dec;135(6):1145-56. Am J Pathol. 1989. PMID: 2596574 Free PMC article.
Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.
Ratech H, Greco MA, Gallo G, Rimoin DL, Kamino H, Hirschhorn R. Ratech H, et al. Am J Pathol. 1985 Jul;120(1):157-69. Am J Pathol. 1985. PMID: 4014441 Free PMC article.
Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycin in vivo.
Bagasra O, Howeedy A, Pomerantz RJ. Bagasra O, et al. Clin Exp Immunol. 1992 Jun;88(3):383-8. doi: 10.1111/j.1365-2249.1992.tb06458.x. Clin Exp Immunol. 1992. PMID: 1535036 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Research Materials
- NCI CPTC Antibody Characterization Program